• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新冠疾病监测中时空异质性对流行病学参数和病例增长率的影响。

Impact of spatiotemporal heterogeneity in COVID-19 disease surveillance on epidemiological parameters and case growth rates.

机构信息

Department of Biology, University of Oxford, United Kingdom.

Department of Biology, University of Oxford, United Kingdom; Department of Computer Science, University of Oxford, United Kingdom.

出版信息

Epidemics. 2022 Dec;41:100627. doi: 10.1016/j.epidem.2022.100627. Epub 2022 Sep 5.

DOI:10.1016/j.epidem.2022.100627
PMID:36099708
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9443927/
Abstract

SARS-CoV-2 case data are primary sources for estimating epidemiological parameters and for modelling the dynamics of outbreaks. Understanding biases within case-based data sources used in epidemiological analyses is important as they can detract from the value of these rich datasets. This raises questions of how variations in surveillance can affect the estimation of epidemiological parameters such as the case growth rates. We use standardised line list data of COVID-19 from Argentina, Brazil, Mexico and Colombia to estimate delay distributions of symptom-onset-to-confirmation, -hospitalisation and -death as well as hospitalisation-to-death at high spatial resolutions and throughout time. Using these estimates, we model the biases introduced by the delay from symptom-onset-to-confirmation on national and state level case growth rates (rt) using an adaptation of the Richardson-Lucy deconvolution algorithm. We find significant heterogeneities in the estimation of delay distributions through time and space with delay difference of up to 19 days between epochs at the state level. Further, we find that by changing the spatial scale, estimates of case growth rate can vary by up to 0.13 d. Lastly, we find that states with a high variance and/or mean delay in symptom-onset-to-diagnosis also have the largest difference between the rt estimated from raw and deconvolved case counts at the state level. We highlight the importance of high-resolution case-based data in understanding biases in disease reporting and how these biases can be avoided by adjusting case numbers based on empirical delay distributions. Code and openly accessible data to reproduce analyses presented here are available.

摘要

SARS-CoV-2 病例数据是估计流行病学参数和模拟疫情动态的主要来源。了解流行病学分析中使用的基于病例的数据源中的偏差非常重要,因为它们会降低这些丰富数据集的价值。这就提出了一个问题,即监测的变化如何影响流行病学参数的估计,例如病例增长率。我们使用来自阿根廷、巴西、墨西哥和哥伦比亚的标准化 COVID-19 病例清单数据,以高空间分辨率和整个时间范围内估计症状出现到确诊、住院和死亡的延迟分布,以及住院到死亡的延迟分布。使用这些估计值,我们使用理查德森-露西反卷积算法的改编版,模拟了从症状出现到确诊的延迟对国家和州级病例增长率(rt)的引入偏差。我们发现,随着时间和空间的推移,延迟分布的估计存在显著的异质性,在州级水平上,不同时期的延迟差异高达 19 天。此外,我们发现,通过改变空间尺度,病例增长率的估计值可能会相差 0.13 天。最后,我们发现,在症状出现到诊断的延迟方面具有高方差和/或均值的州,其 rt 的估计值与州级原始和反卷积病例数之间的差异也最大。我们强调了基于病例的高分辨率数据在理解疾病报告偏差方面的重要性,以及如何通过根据经验延迟分布调整病例数量来避免这些偏差。重现这里呈现的分析的代码和公开可访问的数据是可用的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c07/9443927/ad49a1937866/gr6_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c07/9443927/a3beb2a7d10a/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c07/9443927/5bba259522bb/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c07/9443927/3b38f31d024c/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c07/9443927/c6e0513d643d/gr4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c07/9443927/97d01d624750/gr5_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c07/9443927/ad49a1937866/gr6_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c07/9443927/a3beb2a7d10a/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c07/9443927/5bba259522bb/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c07/9443927/3b38f31d024c/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c07/9443927/c6e0513d643d/gr4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c07/9443927/97d01d624750/gr5_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c07/9443927/ad49a1937866/gr6_lrg.jpg

相似文献

1
Impact of spatiotemporal heterogeneity in COVID-19 disease surveillance on epidemiological parameters and case growth rates.新冠疾病监测中时空异质性对流行病学参数和病例增长率的影响。
Epidemics. 2022 Dec;41:100627. doi: 10.1016/j.epidem.2022.100627. Epub 2022 Sep 5.
2
Generative Bayesian modeling to nowcast the effective reproduction number from line list data with missing symptom onset dates.基于生成式贝叶斯模型,利用缺失症状出现日期的清单数据对有效繁殖数进行实时预测。
PLoS Comput Biol. 2024 Apr 16;20(4):e1012021. doi: 10.1371/journal.pcbi.1012021. eCollection 2024 Apr.
3
Using multiple sampling strategies to estimate SARS-CoV-2 epidemiological parameters from genomic sequencing data.利用多种采样策略从基因组测序数据估算 SARS-CoV-2 流行病学参数。
Nat Commun. 2022 Sep 23;13(1):5587. doi: 10.1038/s41467-022-32812-0.
4
Reconstructing COVID-19 incidences from positive RT-PCR tests by deconvolution.通过反卷积重建阳性 RT-PCR 检测的 COVID-19 感染情况。
BMC Infect Dis. 2023 Oct 11;23(1):679. doi: 10.1186/s12879-023-08667-1.
5
Antibody tests for identification of current and past infection with SARS-CoV-2.用于识别当前和既往感染新型冠状病毒2的抗体检测。
Cochrane Database Syst Rev. 2020 Jun 25;6(6):CD013652. doi: 10.1002/14651858.CD013652.
6
Estimating the Epidemic Size of Superspreading Coronavirus Outbreaks in Real Time: Quantitative Study.实时估计超级传播冠状病毒暴发的流行规模:定量研究。
JMIR Public Health Surveill. 2024 Feb 12;10:e46687. doi: 10.2196/46687.
7
Epidemiological characteristics and transmission dynamics of the outbreak caused by the SARS-CoV-2 Omicron variant in Shanghai, China: a descriptive study.中国上海新型冠状病毒奥密克戎变异株引发疫情的流行病学特征及传播动力学:一项描述性研究
medRxiv. 2022 Jun 18:2022.06.11.22276273. doi: 10.1101/2022.06.11.22276273.
8
Risk factors for severe COVID-19 outcomes in LATAM countries in the post-vaccination era: an analysis of national surveillance data in Argentina, Brazil, Colombia, and Mexico.疫苗接种后时代拉丁美洲国家严重新冠疫情后果的风险因素:对阿根廷、巴西、哥伦比亚和墨西哥国家监测数据的分析
J Glob Health. 2025 Apr 28;15:04141. doi: 10.7189/jogh.15.04141.
9
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
10
Inference of COVID-19 epidemiological distributions from Brazilian hospital data.从巴西医院数据推断 COVID-19 的流行病学分布。
J R Soc Interface. 2020 Nov;17(172):20200596. doi: 10.1098/rsif.2020.0596. Epub 2020 Nov 25.

引用本文的文献

1
A vaccination-based COVID-19 model: Analysis and prediction using Hamiltonian Monte Carlo.一种基于疫苗接种的新冠病毒模型:使用哈密顿蒙特卡洛方法进行分析与预测
Heliyon. 2024 Sep 23;10(19):e38204. doi: 10.1016/j.heliyon.2024.e38204. eCollection 2024 Oct 15.
2
Changing COVID-19 cases and deaths detection in Florida.佛罗里达州新冠病例和死亡人数检测变化。
PLoS One. 2024 Mar 28;19(3):e0299143. doi: 10.1371/journal.pone.0299143. eCollection 2024.
3
Data needs for better surveillance and response to infectious disease threats.加强传染病监测与应对所需的数据。

本文引用的文献

1
Stan: A Probabilistic Programming Language.斯坦:一种概率编程语言。
J Stat Softw. 2017;76. doi: 10.18637/jss.v076.i01. Epub 2017 Jan 11.
2
Using multiple sampling strategies to estimate SARS-CoV-2 epidemiological parameters from genomic sequencing data.利用多种采样策略从基因组测序数据估算 SARS-CoV-2 流行病学参数。
Nat Commun. 2022 Sep 23;13(1):5587. doi: 10.1038/s41467-022-32812-0.
3
Are epidemic growth rates more informative than reproduction numbers?流行增长率是否比繁殖数更具信息量?
Epidemics. 2023 Jun;43:100685. doi: 10.1016/j.epidem.2023.100685. Epub 2023 Apr 13.
J R Stat Soc Ser A Stat Soc. 2022 May 26. doi: 10.1111/rssa.12867.
4
Deciphering early-warning signals of SARS-CoV-2 elimination and resurgence from limited data at multiple scales.从多尺度有限数据中破译 SARS-CoV-2 消除和再现的预警信号。
J R Soc Interface. 2021 Dec;18(185):20210569. doi: 10.1098/rsif.2021.0569. Epub 2021 Dec 15.
5
Monitoring key epidemiological parameters of SARS-CoV-2 transmission.监测新冠病毒传播的关键流行病学参数。
Nat Med. 2021 Nov;27(11):1854-1855. doi: 10.1038/s41591-021-01545-w.
6
The next phase of SARS-CoV-2 surveillance: real-time molecular epidemiology.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)监测的下一阶段:实时分子流行病学
Nat Med. 2021 Sep;27(9):1518-1524. doi: 10.1038/s41591-021-01472-w. Epub 2021 Sep 9.
7
Benchmarking the Covid-19 pandemic across countries and states in the USA under heterogeneous testing.在异质检测下对各国和美国各州的新冠疫情进行基准测试。
Sci Rep. 2021 Jul 26;11(1):15199. doi: 10.1038/s41598-021-94663-x.
8
Dating first cases of COVID-19.追溯新冠病毒病的首例病例。
PLoS Pathog. 2021 Jun 24;17(6):e1009620. doi: 10.1371/journal.ppat.1009620. eCollection 2021 Jun.
9
Challenges in control of COVID-19: short doubling time and long delay to effect of interventions.控制 COVID-19 的挑战:短的倍增时间和干预效果的长延迟。
Philos Trans R Soc Lond B Biol Sci. 2021 Jul 19;376(1829):20200264. doi: 10.1098/rstb.2020.0264. Epub 2021 May 31.
10
The Impact of Changes in Diagnostic Testing Practices on Estimates of COVID-19 Transmission in the United States.诊断检测实践变化对美国 COVID-19 传播估计的影响。
Am J Epidemiol. 2021 Sep 1;190(9):1908-1917. doi: 10.1093/aje/kwab089.